Literature DB >> 32619192

Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.

Mario Plebani1,2, Andrea Padoan1,2, Laura Sciacovelli2, Daniela Basso1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32619192     DOI： 10.1515/cclm-2020-0880

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  2 in total

1.  The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers.

Authors:  Yurie Kobashi; Yuzo Shimazu; Yoshitaka Nishikawa; Takeshi Kawamura; Tatsuhiko Kodama; Daiji Obara; Masaharu Tsubokura
Journal:  Int Immunopharmacol       Date:  2020-12-30       Impact factor: 5.714

2.  Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).

Authors:  Akihisa Mitani; Kensuke Hamada; Naoyuki Yoshikawa; Yoshifumi Morita; Takeshi Horie; Yukiko Inoue; Minako Saito; Takashi Ishii; Mitsuhiro Sunohara; Ryota Takahashi; Noriko Emoto; Nahoko Nishimoto; Yoko Murano; Sachiko Okazaki; Shoko Tateishi; Atsushi Yao; Takuya Shimura; Makoto Kurano; Yutaka Yatomi; Shintaro Yanagimoto
Journal:  J Infect Chemother       Date:  2021-06-12       Impact factor: 2.211
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.